NCT05701631 is a clinical trial of Radiomic model in Pneumocystis Jirovecii Pneumonia, sponsored by Chinese PLA General Hospital.

Who is sponsoring NCT05701631?

NCT05701631 is sponsored by Chinese PLA General Hospital.

What drugs are being tested in NCT05701631?

Interventions in NCT05701631: Radiomic model.

What condition does NCT05701631 study?

NCT05701631 studies Pneumocystis Jirovecii Pneumonia.

Is NCT05701631 still recruiting?

NCT05701631 is currently status unknown. Last updated 27 January 2023.

Last reviewed 2023-01-27 · How we verify

NCT05701631

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radiomics Model for the Diagnosis of Pneumocystis Jirovecii Pneumonia in Non-HIV Patients

Status unknown Last updated 27 January 2023

What this trial tests

trial testing Radiomic model in Pneumocystis Jirovecii Pneumonia in 140 participants. Status unknown.

Timeline

15 January 2023

Primary endpoint
30 June 2023

30 June 2023

Quick facts

Lead sponsor	Chinese PLA General Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	140
Start date	15 January 2023
Primary completion	30 June 2023
Estimated completion	30 June 2023
Sites	1 location across China

Drugs / interventions tested

Radiomic model

Conditions studied

Pneumocystis Jirovecii Pneumonia — all drugs for Pneumocystis Jirovecii Pneumonia →

Sponsor

Chinese PLA General Hospital

Who can join

18 and older, any sex, with Pneumocystis Jirovecii Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the performance of radiomics in differentiating Pneumocystis jirovecii pneumonia (PCP) from other types of pneumonia and to improve the diagnostic efficacy of non-invasive tests in non-HIV patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Computed tomography-based radiomics improves non-invasive diagnosis of Pneumocystis jirovecii pneumonia in non-HIV patients: a retrospective study.
Yu H, Yang Z, Wei Y, Shi W, et al · · 2024 · cited 7× · PMID 38167022 · DOI 10.1186/s12890-023-02827-4

Verify or expand the search:

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

NCT07294755 — The Impact of Intrapleural Block on Postoperative Pain Caused by Drainage Tubes After Thoracoscopic Surgery · NA · not yet recruiting
NCT07536607 — Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients · not yet recruiting
NCT07489157 — Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy · NA · not yet recruiting
NCT07494981 — Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations · not yet recruiting
NCT07496008 — Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05701631 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese PLA General Hospital
Last refreshed: 27 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05701631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing